Opinion
Video
Dosing Regimens and Treatment Efficacy of FcRn Inhibitors in Generalized Myasthenia Gravis
Author(s):
Key Takeaways
- FcRn inhibitors have distinct dosing and administration protocols, necessitating careful consideration by clinicians for optimal therapeutic outcomes.
- Adherence to specific dosing guidelines is crucial to maximize efficacy and minimize adverse effects in patients receiving FcRn inhibitors.
Panelists discuss how they approach and potentially adapt the dosing and administration regimens of approved and investigational FcRn inhibitors in their myasthenia gravis patients, considering the prescribed guidelines and individual patient needs.
Video content above is prompted by the following:
- Approved and investigational FcRn inhibitors have different dosing/administration regimens.
- Do you follow these dosing regimens in your patients?
Related Videos
Related Content
